174 related articles for article (PubMed ID: 19238554)
1. Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study.
Sapra B; Jain S; Tiwary AK
AAPS PharmSciTech; 2009; 10(1):199-210. PubMed ID: 19238554
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture.
Sapra B; Jain S; Tiwary AK
Drug Dev Ind Pharm; 2009 Oct; 35(10):1230-41. PubMed ID: 19555244
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.
Sapra B; Jain S; Tiwary AK
Drug Deliv; 2008 Sep; 15(7):443-54. PubMed ID: 18712622
[TBL] [Abstract][Full Text] [Related]
4. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
Ubaidulla U; Reddy MV; Ruckmani K; Ahmad FJ; Khar RK
AAPS PharmSciTech; 2007 Jan; 8(1):2. PubMed ID: 17408218
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of carvedilol transdermal patches.
Tanwar YS; Chauhan CS; Sharma A
Acta Pharm; 2007 Jun; 57(2):151-9. PubMed ID: 17507312
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
Dixit N; Kohli K; Baboota S
PDA J Pharm Sci Technol; 2008; 62(1):46-55. PubMed ID: 18402367
[TBL] [Abstract][Full Text] [Related]
8. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
Aboelwafa AA; El-Setouhy DA; Elmeshad AN
AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers.
Amin S; Kohli K; Khar RK; Mir SR; Pillai KK
Pharm Dev Technol; 2008; 13(6):533-9. PubMed ID: 18720242
[TBL] [Abstract][Full Text] [Related]
11. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
12. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis.
Krishnaiah YS; Satyanarayana V; Karthikeyan RS
J Pharm Pharm Sci; 2002; 5(2):123-30. PubMed ID: 12207864
[TBL] [Abstract][Full Text] [Related]
13. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.
Wei L; Li J; Guo L; Nie S; Pan W; Sun P; Liu H
Drug Dev Ind Pharm; 2007 Sep; 33(9):990-8. PubMed ID: 17891586
[TBL] [Abstract][Full Text] [Related]
14. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
15. Development of novel interpenetrating network gellan gum-poly(vinyl alcohol) hydrogel microspheres for the controlled release of carvedilol.
Agnihotri SA; Aminabhavi TM
Drug Dev Ind Pharm; 2005 Jul; 31(6):491-503. PubMed ID: 16109622
[TBL] [Abstract][Full Text] [Related]
16. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
Thimmasetty J; Pandey G; Babu P
Pak J Pharm Sci; 2008 Jul; 21(3):241-8. PubMed ID: 18614419
[TBL] [Abstract][Full Text] [Related]
17. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry.
Poggi JC; Da Silva FG; Coelho EB; Marques MP; Bertucci C; Lanchote VL
Chirality; 2012 Mar; 24(3):209-14. PubMed ID: 22271587
[TBL] [Abstract][Full Text] [Related]
18. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.
Bertera F; Di Verniero CA; Mayer MA; Chiappetta D; Buontempo F; Polizio AH; Taira CA; Höcht C
Xenobiotica; 2012 Feb; 42(2):206-19. PubMed ID: 21892881
[TBL] [Abstract][Full Text] [Related]
20. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
